Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: theInformer
1
Jul 02, 2009 10:58AM

Had S&L been allowed to continue exercising the convertible notes, including resets, I humbly suggest that the O/S would be nearer to 1,000,000,000 shares than the currently authorised 600,000,000.

What price then PTSC?

Be well

Share
New Message
Please login to post a reply